source
- STAT+: FDA staff and peptide enthusiasts set to clash at advisory panelFDA advisers are set to consider whether allowing compounding pharmacies to offer largely unproven peptides is a safer bet than the gray-market versions now in use.STAT · 6d ago↗ source
- Recon: J&J nabs FDA authorization for general surgery robot; FDA urged to ban DTC drug adsWelcome to Regulatory Reconnaissance, your regulatory news and intelligence briefing.raps · 6d ago↗ source
- Euro Roundup: EMA seeks feedback on planned changes to guidance on biosimilar efficacy studiesThe European Medicines Agency (EMA) has released a draft concept paper on planned changes to its guideline on similar biological medicinal products.raps · 6d ago